Development and Implementation of an Evidence-Based Process for Scarce Resource Allocation

Authors

Richard K. Ogden Jr., Children's Mercy HospitalFollow
Daniel L. Millspaugh, Children's Mercy HospitalFollow
Brian O'Neal, Children's Mercy Kansas CityFollow

Publication Date

10-2019

Files

Abstract

Background: Intravenous immune globulin (IVIG) is a plasma-derived product from pooled donors. It has six FDA approved indications. It is also considered standard of care for a few other conditions in specific populations. Additionally, there is growing non-evidence-based use. Due to a global shortage, IVIG has become increasing difficult to obtain.

. . . .

Conclusions: Development, implementation, and promotion of adherence to an evidence-based criterion allowed our scarce IVIG supply to be sustained. Further refinement of the criteria for use is ongoing, as is an evaluation of IVIG utilization by indication, pre- and post-implementation. This process can be applied to other situations of scarce resources

MeSH Keywords

Immunoglobulins, Intravenous; Evidence-Based Practice; Resource Allocation; Quality Improvement

Keywords

IVIG

Disciplines

Health and Medical Administration | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Ogden, Richard K. Jr.; Millspaugh, Daniel L.; and O'Neal, Brian, "Development and Implementation of an Evidence-Based Process for Scarce Resource Allocation" (2019). Posters. 138.
https://scholarlyexchange.childrensmercy.org/posters/138